CASR Gene Hypocalcemia Autosomal Dominant with Bartter Syndrome NGS Genetic DNA Test
Comprehensive Genetic Testing for Calcium Metabolism Disorders
The CASR Gene Hypocalcemia Autosomal Dominant with Bartter Syndrome NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare inherited calcium metabolism disorders. This sophisticated genetic analysis utilizes next-generation sequencing technology to identify mutations in the calcium-sensing receptor (CASR) gene, which plays a critical role in maintaining calcium homeostasis throughout the body.
What Does This Test Measure?
This advanced genetic test specifically targets and analyzes the CASR gene located on chromosome 3q21.1. The test detects:
- Point mutations in the CASR gene coding regions
- Small insertions and deletions affecting gene function
- Genetic variations associated with autosomal dominant hypocalcemia
- Mutations linked to Bartter syndrome manifestations
- Pathogenic variants affecting calcium-sensing receptor function
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals presenting with:
- Persistent hypocalcemia with low serum calcium levels
- Recurrent muscle cramps and tetany episodes
- Neurological symptoms including seizures and paresthesia
- Family history of calcium metabolism disorders
- Unexplained renal complications and electrolyte imbalances
- Developmental delays in children with calcium abnormalities
- Suspected Bartter syndrome features with hypocalcemia
Clinical Benefits of CASR Gene Testing
Undergoing this comprehensive genetic analysis provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out CASR-related disorders with high precision
- Personalized Treatment: Enables targeted calcium and vitamin D therapy
- Genetic Counseling: Provides essential information for family planning
- Early Intervention: Facilitates proactive management of complications
- Disease Monitoring: Helps track treatment effectiveness over time
- Research Contribution: Advances understanding of rare calcium disorders
Understanding Your Test Results
Our genetic specialists provide comprehensive interpretation of your results:
- Positive Result: Indicates presence of pathogenic CASR gene mutation, confirming diagnosis of autosomal dominant hypocalcemia
- Negative Result: Suggests absence of detectable CASR mutations, though clinical correlation remains essential
- Variant of Uncertain Significance: Requires additional family studies and clinical evaluation
- Carrier Status: Important information for genetic counseling and family planning
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| CASR Gene Hypocalcemia Autosomal Dominant with Bartter Syndrome NGS Genetic DNA Test – Discount Price | $500 |
| CASR Gene Hypocalcemia Autosomal Dominant with Bartter Syndrome NGS Genetic DNA Test – Regular Price | $700 |
Nationwide Testing Availability
We proudly offer this advanced genetic testing service across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Control of Your Genetic Health Today
Don’t let uncertainty about calcium metabolism disorders affect your quality of life. Our CASR Gene Hypocalcemia Autosomal Dominant with Bartter Syndrome NGS Genetic DNA Test provides the clarity you need for proper diagnosis and treatment. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are ready to help you understand your risk and develop a personalized management plan.
